Mankind Pharma jumped 5.31% to Rs 4,240.75 after the company's consolidated net profit surged 30.43% to Rs 653.47 crore on a 13.6% rise in revenue to Rs 3,076.51 crore in Q2 FY25, compared to Q2 FY24.

As the U.K. works to pump fresh cash into the local biopharma scene, London’s Accord Healthcare is capitalizing on the government’s renewed willingness to chip in. | Flush with a 50 million pound ...

marking a significant milestone for the company's commitment to quality and technological innovation. Chandigarh, Nov 5 (PTI) ...

With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...

Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets, a medication used for treatment of high ...

Increasingly, injectables manufacturers recognise that to achieve maximum profitability, they need to focus on the value they provide.

“This partnership will leverage our advanced biologics manufacturing facility at Genome ... given the CEO’s limited experience in these key pharma regions, which account for 75 percent of the ...

Sheikh Saqer Bin Humaid Al Qasimi, Chairman of the Board, Julphar, said: “The divestment of our retail pharmacies operations ...

French industrial production fell back in September, quashing some of the gains made earlier in the quarter. Output of goods ...

MilliporeSigma has about 1,700 employees in Wisconsin at facilities in Milwaukee, Port Washington, Sheboygan and in the ...

NJ Bio and Charles River Announce a Strategic Alliance to Advance ADC Development and Manufacturing Services ...

IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2024.